Technical Analysis for TTOO - T2 Biosystems, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 3.65% | |
| Lower Bollinger Band Walk | Weakness | 3.65% | |
| Stochastic Reached Oversold | Weakness | 3.65% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 3.65% | |
| Lower Bollinger Band Touch | Weakness | 3.65% | |
| Oversold Stochastic | Weakness | 3.65% | |
| Hammer Candlestick | Bullish | 2.90% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 9 hours ago |
| Rose Above 10 DMA | about 9 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
| Up 5% | about 10 hours ago |
| Possible Inside Day | about 11 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/06/2024
T2 Biosystems, Inc. Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products based on its proprietary platform. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument, which has completed a pivotal clinical trial for performing diagnostic tests in sepsis and other applications; and T2Stat, an integrated instrument for hemostasis applications. It is also developing T2Candida panel that has completed a pivotal clinical trial for identifying pathogens associated with sepsis; T2HemoStat panel, which includes a set of hemostasis measurements, including platelet function, clotting time, and clot degradation; and T2Bacteria, a multiplex diagnostic panel that detects the bacterial pathogens associated with sepsis. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cell Biology Biomarkers In Vitro Diagnostic Products Diagnostic Tests Magnetic Resonance Blood Plasma Blood Coagulation Intensive Care Medicine In Vitro Diagnostics Pivotal Platelet Coagulation System Hemostasis Sepsis Whole Blood
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.46 |
| 52 Week Low | 0.054 |
| Average Volume | 219,489 |
| 200-Day Moving Average | 3.13 |
| 50-Day Moving Average | 3.88 |
| 20-Day Moving Average | 2.94 |
| 10-Day Moving Average | 2.91 |
| Average True Range | 0.34 |
| RSI (14) | 40.12 |
| ADX | 18.09 |
| +DI | 17.42 |
| -DI | 15.18 |
| Chandelier Exit (Long, 3 ATRs) | 2.38 |
| Chandelier Exit (Short, 3 ATRs) | 3.62 |
| Upper Bollinger Bands | 3.22 |
| Lower Bollinger Band | 2.66 |
| Percent B (%b) | 0.32 |
| BandWidth | 18.88 |
| MACD Line | -0.24 |
| MACD Signal Line | -0.28 |
| MACD Histogram | 0.0409 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.19 | ||||
| Resistance 3 (R3) | 3.19 | 3.06 | 3.13 | ||
| Resistance 2 (R2) | 3.06 | 2.97 | 3.06 | 3.11 | |
| Resistance 1 (R1) | 2.95 | 2.91 | 3.01 | 2.96 | 3.09 |
| Pivot Point | 2.83 | 2.83 | 2.85 | 2.83 | 2.83 |
| Support 1 (S1) | 2.71 | 2.74 | 2.77 | 2.72 | 2.59 |
| Support 2 (S2) | 2.59 | 2.68 | 2.59 | 2.57 | |
| Support 3 (S3) | 2.48 | 2.59 | 2.55 | ||
| Support 4 (S4) | 2.49 |
